Loading...

Clinical Practice Guidelines

Management of Wilson’s Disease

Recommendations are based on a systematic literature review in the Medline (PubMed version), Embase (Dialog version), and the Cochrane Library databases using entries from 1966 to 2011. The Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) system used in other EASL CPGs was used and set against the somewhat different grading system used in the…
Read more

Management of Hepatitis C Virus Infection

Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. The long-term hepatic impact of HCV infection is highly variable, from minimal changes to chronic hepatitis, extensive fibrosis, and cirrhosis with or without hepatocellular carcinoma (HCC). The number of chronically infected persons worldwide may exceed 200 million, but most…
Read more

Management of Ascites, Spontaneous Bacterial Peritonitis, and Hepatorenal Syndrome in Cirrhosis

EASL has published clinical practice guidelines for the management of ascites, the most common complication of cirrhosis. The peer-reviewed guidelines are available in the September 2010 issue, (Volume 53, No.3) of the Journal of Hepatology and online CPGs. They will also provide recommendations for the management of spontaneous bacterial peritonitis (SBP) and hepatorenal syndrome, which…
Read more

Management of HFE Hemochromatosis

EASL is pleased to announce the publication of its 3rd Clinical Practice Guidelines on the Management of HFE Hemochromatosis (HFE-HC). 1 in 200 people in northern Europe are affected by hemochromatosis, a highly prevalent but somewhat overlooked disease due to its lack of symptoms and difficult diagnosis, making it one of the most common inheritable…
Read more

Management of Cholestatic Liver Diseases

In October 2008, EASL proudly published its first CPG on the Management of Chronic Hepatitis B. Eight months later, new subject matter was published in the same series of Clinical Practice Guidelines; this time on the Management of Cholestatic Liver Diseases.
Read more
Share
Back To Top